Menu
Back to User profile » Dr Lin Yue
Papers published by Dr Lin Yue:
Metabolic and Hepatic Effects of Empagliflozin on Nonalcoholic Fatty Liver Mice [Corrigendum]
Niu S, Ren Q, Chen S, Pan X, Yue L, Chen X, Li Z, Zhen R
Diabetes, Metabolic Syndrome and Obesity 2023, 16:2833-2834
Published Date: 16 September 2023
Metabolic and Hepatic Effects of Empagliflozin on Nonalcoholic Fatty Liver Mice
Niu S, Ren Q, Chen S, Pan X, Yue L, Chen X, Li Z, Zhen R
Diabetes, Metabolic Syndrome and Obesity 2023, 16:2549-2560
Published Date: 24 August 2023
Mechanisms of Small Intestine Involvement in Obesity-Induced Atherosclerosis
Pan X, Jia Z, Zhen R, Yue L, Niu S, Ban J, Chen S
Diabetes, Metabolic Syndrome and Obesity 2023, 16:1941-1952
Published Date: 28 June 2023
Association of Neutrophil to High-Density Lipoprotein Cholesterol Ratio with Cardiac Ultrasound Parameters and Cardiovascular Risk: A Cross-Sectional Study Based on Healthy Populations
Pan X, Zhang X, Ban J, Yue L, Ren L, Chen S
Journal of Inflammation Research 2023, 16:1853-1865
Published Date: 27 April 2023
Effects of High-Fat Diet on Cardiovascular Protein Expression in Mice Based on Proteomics
Pan X, Zhang X, Ban J, Yue L, Ren L, Chen S
Diabetes, Metabolic Syndrome and Obesity 2023, 16:873-882
Published Date: 28 March 2023
Effects of Semaglutide on Cardiac Protein Expression and Cardiac Function of Obese Mice
Pan X, Yue L, Ban J, Ren L, Chen S
Journal of Inflammation Research 2022, 15:6409-6425
Published Date: 24 November 2022
Association of Triglyceride-Glucose Index and Liver Function Parameters Among Healthy Obese Civil Servants: A Center-Based Study
Pan X, Yue L, Ren L, Ban J, Chen S
Diabetes, Metabolic Syndrome and Obesity 2022, 15:3519-3531
Published Date: 14 November 2022
Metabolomics Provides Insights into Renoprotective Effects of Semaglutide in Obese Mice
Chen X, Chen S, Ren Q, Niu S, Pan X, Yue L, Li Z, Zhu R, Jia Z, Chen X, Zhen R, Ban J
Drug Design, Development and Therapy 2022, 16:3893-3913
Published Date: 9 November 2022
An Effective Glucagon-Like Peptide-1 Receptor Agonists, Semaglutide, Improves Sarcopenic Obesity in Obese Mice by Modulating Skeletal Muscle Metabolism
Ren Q, Chen S, Chen X, Niu S, Yue L, Pan X, Li Z, Chen X
Drug Design, Development and Therapy 2022, 16:3723-3735
Published Date: 25 October 2022